News

From our CEO

20 May 2025

Rohan Greenland The May 50K

First, an enormous thank you to all who have taken part or supported someone undertaking the iconic May 50K, our single most important fundraising event for MS research. Your support – as a participant, donor or supporter – is critically important for Australian MS research.

Your dollars help propel us further and faster down the pathways to cures, with cutting-edge Australian research increasingly globally linked and aligned to the international effort to drive prevention, early detection, improved treatment and ultimately a cure.

Second, we have been busy in this post-election period, congratulating newly appointed ministers, asking for early meetings and extending our appreciation for a new portfolio alignment across the health, ageing and disability disciplines.

While it was no surprise that the accomplished health minister, Mark Butler, was reappointed, it was a surprise to find his responsibilities extended to include the NDIS and disability.

While some in the disability sector see this as a detrimental move, I support it, especially as it aligns with a key policy priority supported by MSA and the Neurological Alliance Australia, calling for better alignment across the disability, health and aged care portfolios.

While this is a welcome alignment, it is still just that – an alignment. We will move heaven and earth to see that the better integration of services and improved access to care is realised as a result of this reshuffle of responsibilities.

But it’s a good start, and we look forward to an early meeting with ministers new and old in this super-ministry.

We also look forward to early meetings with cross-bench and opposition health spokespersons, including the re-elected independent member for Kooyong, Monique Ryan, a paediatric neurologist.

We will be pushing the case for a national action plan for neurological conditions, sustained funding for neurological research – including MS research – under the Medical Research Future Fund, a national neurological data set – because we still haven’t got one – and support for an MS Biobank.

The election may be over, but our advocacy mission continues with fresh passion. Because people living with MS and other neurological conditions are still not getting the support they so desperately need.

Related News

MS News

PBAC rapid review of MS medicines: what it means for the MS community

13 August 2026

Further details have now been announced about the Pharmaceutical Benefits Advisory Committee’s rapid review of medicines listed on the Pharmaceutical Benefits Scheme (PBS) for relapsing-remitting multiple sclerosis. 

MS News

Susan Hyde

29 July 2026

Susan reflects on her journey with MS from a young age, her diagnosis story and the importance of building a strong support network.

MS News

Researchers turn to lab-grown ‘mini brains’ in search of ways to repair MS damage

29 July 2026

The research, funded through MS Australia's mid-year grants round and based at The Florey Institute of Neuroscience and Mental Health, will investigate how the brain naturally produces myelin, the protective coating around nerve fibres that is damaged by MS. 

Read More

Newsletter subscription

  • This field is for validation purposes and should be left unchanged.

From our CEO